Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,320 | 1,920 | 4,120 | 5,430 | 6,590 |
| Receivables | 6,380 | 6,100 | 4,734 | 4,740 | 4,210 |
| Other current assets | 570 | 610 | 0 | 400 | 440 |
| TOTAL | $10,270 | $8,630 | $9,796 | $10,570 | $11,240 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 3,320 | N/A | N/A |
| TOTAL | $N/A | $N/A | $3,320 | $N/A | $N/A |
| Total Assets | $11,580 | $9,510 | $10,602 | $11,870 | $12,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,690 | 1,020 | 1,240 | 1,350 | 1,250 |
| Accrued Expenses | 2,140 | 2,760 | 3,150 | 2,370 | 1,860 |
| Other current liabilities | 820 | 1,150 | 1,510 | 2,330 | 2,360 |
| TOTAL | $4,670 | $4,940 | $5,922 | $6,060 | $5,480 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 1,519 | N/A | N/A |
| TOTAL | $30 | $70 | $100 | $350 | $840 |
| Total Liabilities | $12,560 | $12,860 | $6,022 | $6,410 | $6,320 |
| Shareholders' Equity | |||||
| Common Shares | 7,980 | 7,970 | 7,970 | 7,970 | 7,970 |
| Retained earnings | -44,160 | -44,070 | -43,817 | -42,720 | -41,660 |
| Other shareholders' equity | -8,070 | -8,070 | -184 | -190 | -190 |
| TOTAL | $-970 | $-3,350 | $4,579 | $5,460 | $6,180 |
| Total Liabilities And Equity | $11,590 | $9,510 | $10,601 | $11,870 | $12,500 |